162 related articles for article (PubMed ID: 14691637)
1. Expression profiling of favorable and unfavorable neuroblastomas.
Hiyama E; Hiyama K; Yamaoka H; Sueda T; Reynolds CP; Yokoyama T
Pediatr Surg Int; 2004 Jan; 20(1):33-8. PubMed ID: 14691637
[TBL] [Abstract][Full Text] [Related]
2. Differential gene expression profiles between neuroblastomas with high telomerase activity and low telomerase activity.
Hiyama E; Hiyama K; Nishiyama M; Reynolds CP; Shay JW; Yokoyama T
J Pediatr Surg; 2003 Dec; 38(12):1730-4. PubMed ID: 14666454
[TBL] [Abstract][Full Text] [Related]
3. Novel risk stratification of patients with neuroblastoma by genomic signature, which is independent of molecular signature.
Tomioka N; Oba S; Ohira M; Misra A; Fridlyand J; Ishii S; Nakamura Y; Isogai E; Hirata T; Yoshida Y; Todo S; Kaneko Y; Albertson DG; Pinkel D; Feuerstein BG; Nakagawara A
Oncogene; 2008 Jan; 27(4):441-9. PubMed ID: 17637744
[TBL] [Abstract][Full Text] [Related]
4. Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas.
Westermann F; Muth D; Benner A; Bauer T; Henrich KO; Oberthuer A; Brors B; Beissbarth T; Vandesompele J; Pattyn F; Hero B; König R; Fischer M; Schwab M
Genome Biol; 2008 Oct; 9(10):R150. PubMed ID: 18851746
[TBL] [Abstract][Full Text] [Related]
5. Expression of NLRR3 orphan receptor gene is negatively regulated by MYCN and Miz-1, and its downregulation is associated with unfavorable outcome in neuroblastoma.
Akter J; Takatori A; Hossain MS; Ozaki T; Nakazawa A; Ohira M; Suenaga Y; Nakagawara A
Clin Cancer Res; 2011 Nov; 17(21):6681-92. PubMed ID: 21908575
[TBL] [Abstract][Full Text] [Related]
6. Dissection of the oncogenic MYCN transcriptional network reveals a large set of clinically relevant cell cycle genes as drivers of neuroblastoma tumorigenesis.
Murphy DM; Buckley PG; Bryan K; Watters KM; Koster J; van Sluis P; Molenaar J; Versteeg R; Stallings RL
Mol Carcinog; 2011 Jun; 50(6):403-11. PubMed ID: 21557326
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of genes identified by microarray analysis in favorable neuroblastoma.
Kamei N; Hiyama K; Yamaoka H; Kamimatsuse A; Onitake Y; Sueda T; Hiyama E
Pediatr Surg Int; 2009 Nov; 25(11):931-7. PubMed ID: 19701758
[TBL] [Abstract][Full Text] [Related]
8. Low expression of Wnt-5a gene is associated with high-risk neuroblastoma.
Blanc E; Roux GL; Bénard J; Raguénez G
Oncogene; 2005 Feb; 24(7):1277-83. PubMed ID: 15592517
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide analysis of gene expression associated with MYCN in human neuroblastoma.
Alaminos M; Mora J; Cheung NK; Smith A; Qin J; Chen L; Gerald WL
Cancer Res; 2003 Aug; 63(15):4538-46. PubMed ID: 12907629
[TBL] [Abstract][Full Text] [Related]
10. The calcium-sensing receptor is silenced by genetic and epigenetic mechanisms in unfavorable neuroblastomas and its reactivation induces ERK1/2-dependent apoptosis.
Casalà C; Gil-Guiñón E; Ordóñez JL; Miguel-Queralt S; Rodríguez E; Galván P; Lavarino C; Munell F; de Alava E; Mora J; de Torres C
Carcinogenesis; 2013 Feb; 34(2):268-76. PubMed ID: 23108190
[TBL] [Abstract][Full Text] [Related]
11. Dickkopf-1 is down-regulated by MYCN and inhibits neuroblastoma cell proliferation.
Koppen A; Ait-Aissa R; Hopman S; Koster J; Haneveld F; Versteeg R; Valentijn LJ
Cancer Lett; 2007 Oct; 256(2):218-28. PubMed ID: 17643814
[TBL] [Abstract][Full Text] [Related]
12. High expressions of neuronatin isoforms in favorable neuroblastoma.
Higashi M; Tajiri T; Kinoshita Y; Tatsuta K; Souzaki R; Maehara Y; Suita S; Taguchi T
J Pediatr Hematol Oncol; 2007 Aug; 29(8):551-6. PubMed ID: 17762496
[TBL] [Abstract][Full Text] [Related]
13. Segmental chromosome aberrations converge on overexpression of mitotic spindle regulatory genes in high-risk neuroblastoma.
Ooi WF; Re A; Sidarovich V; Canella V; Arseni N; Adami V; Guarguaglini G; Giubettini M; Scaruffi P; Stigliani S; Lavia P; Tonini GP; Quattrone A
Genes Chromosomes Cancer; 2012 Jun; 51(6):545-56. PubMed ID: 22337647
[TBL] [Abstract][Full Text] [Related]
14. Neuroblastomas with discordant genotype-phenotype relationships: report of four cases with MYCN amplification and favorable histology.
Nakagawa A; Matsuoka K; Okita H; Iwafuchi H; Hori H; Kumagai M
Pediatr Dev Pathol; 2011; 14(2):87-92. PubMed ID: 21288077
[TBL] [Abstract][Full Text] [Related]
15. Ataxin-2 promotes apoptosis of human neuroblastoma cells.
Wiedemeyer R; Westermann F; Wittke I; Nowock J; Schwab M
Oncogene; 2003 Jan; 22(3):401-11. PubMed ID: 12545161
[TBL] [Abstract][Full Text] [Related]
16. Age dependence of tumor genetics in unfavorable neuroblastoma: arrayCGH profiles of 34 consecutive cases, using a Swedish 25-year neuroblastoma cohort for validation.
Cetinkaya C; Martinsson T; Sandgren J; Träger C; Kogner P; Dumanski J; Díaz de Ståhl T; Hedborg F
BMC Cancer; 2013 May; 13():231. PubMed ID: 23656755
[TBL] [Abstract][Full Text] [Related]
17. Subclassification and individual survival time prediction from gene expression data of neuroblastoma patients by using CASPAR.
Oberthuer A; Kaderali L; Kahlert Y; Hero B; Westermann F; Berthold F; Brors B; Eils R; Fischer M
Clin Cancer Res; 2008 Oct; 14(20):6590-601. PubMed ID: 18927300
[TBL] [Abstract][Full Text] [Related]
18. Implication of unfavorable histology, MYCN amplification and diploidy for stage I and II neuroblastomas.
de Buys Roessingh AS; Rougemont AL; Wiesenauer C; Barrette S; Bouron-Dal Soglio D; Lallier M
Eur J Pediatr Surg; 2008 Dec; 18(6):410-4. PubMed ID: 19012235
[TBL] [Abstract][Full Text] [Related]
19. Dickkopf-3 expression is a marker for neuroblastic tumor maturation and is down-regulated by MYCN.
Koppen A; Ait-Aissa R; Koster J; Øra I; Bras J; van Sluis PG; Caron H; Versteeg R; Valentijn LJ
Int J Cancer; 2008 Apr; 122(7):1455-64. PubMed ID: 18059033
[TBL] [Abstract][Full Text] [Related]
20. Hox-C9 activates the intrinsic pathway of apoptosis and is associated with spontaneous regression in neuroblastoma.
Kocak H; Ackermann S; Hero B; Kahlert Y; Oberthuer A; Juraeva D; Roels F; Theissen J; Westermann F; Deubzer H; Ehemann V; Brors B; Odenthal M; Berthold F; Fischer M
Cell Death Dis; 2013 Apr; 4(4):e586. PubMed ID: 23579273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
